<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<ArticleSet>
<Article>
<Journal>
<PublisherName>jmedicalcasereports</PublisherName>
<JournalTitle>Frontiers in Medical Case Reports</JournalTitle>
<PISSN>I</PISSN>
<EISSN>S</EISSN>
<Volume-Issue>Volume 2; Issue 6</Volume-Issue>
<PartNumber/>
<IssueTopic>Multidisciplinary</IssueTopic>
<IssueLanguage>English</IssueLanguage>
<Season>(Nov-Dec, 2021)</Season>
<SpecialIssue>N</SpecialIssue>
<SupplementaryIssue>N</SupplementaryIssue>
<IssueOA>Y</IssueOA>
<PubDate>
<Year>-0001</Year>
<Month>11</Month>
<Day>30</Day>
</PubDate>
<ArticleType>Medical Case Reports</ArticleType>
<ArticleTitle>Sickle Cell Hemoglobin E Disorder – A Case Study in Balasore District of Odisha, India</ArticleTitle>
<SubTitle/>
<ArticleLanguage>English</ArticleLanguage>
<ArticleOA>Y</ArticleOA>
<FirstPage>1</FirstPage>
<LastPage>8</LastPage>
<AuthorList>
<Author>
<FirstName>Somali</FirstName>
<LastName>Das</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>N</CorrespondingAuthor>
<ORCID/>
<FirstName>Apratim Sai</FirstName>
<LastName>Rajesh</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Nibarana</FirstName>
<LastName>Satapathy</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
<FirstName>Bisnu Prasad</FirstName>
<LastName>Dash</LastName>
<AuthorLanguage>English</AuthorLanguage>
<Affiliation/>
<CorrespondingAuthor>Y</CorrespondingAuthor>
<ORCID/>
</Author>
</AuthorList>
<DOI/>
<Abstract>Hemoglobinopathies __ampersandsign are the cause of some major genetic and social health problem in many countries including India and sickle cell disorder is one of the most debilitating genetic disease affecting a large population. Though recognized, in and as various groups of genetic mutations, double heterozygous state of sickle cell and hemoglobin E (HbSE) is uncommon in Odisha state. Due to migration and racial inter-caste marriages between the populations of different neighboring states the possibilities of detecting Hb SE disease in Odisha is rising but this rare case of Hb SE has never been reported in Balasore district so far. In the present instance, a 24 year old male was diagnosed with sickle cell hemoglobin E disorder. The case was confirmed through Hb electrophoresis, slide based sickle test, HPLC and ARMS PCR. The peripheral smear analysis showed the presence of microcytic RBC and Hypochromasia. No splenomegaly and hepatomegaly was observed. The case was mostly asymptomatic and with history of joint and bone pains once or twice per year.</Abstract>
<AbstractLanguage>English</AbstractLanguage>
<Keywords>HbSE,Sickle Cell,Hemoglobin SE,Balasore</Keywords>
<URLs>
<Abstract>https://www.jmedicalcasereports.org/ubijournal-v1copy/journals/abstract.php?article_id=13397&title=Sickle Cell Hemoglobin E Disorder – A Case Study in Balasore District of Odisha, India</Abstract>
</URLs>
<References>
<ReferencesarticleTitle>References</ReferencesarticleTitle>
<ReferencesfirstPage>16</ReferencesfirstPage>
<ReferenceslastPage>19</ReferenceslastPage>
<References>and; Acipayam C, Oktay G, Ilhan G, Mehmet AC. Hemoglobin SE Disease in Hatay, in the Southern Part of Turkey. Thal Rep 2015; 5: 4597.
Ahmed MM, Gravell, D, Ganesh A. Sickle Cell – Haemoglobin E (HbSE) Compound Heterozygosity: A Clinical and Haematological Study. Int J Lab Hematol 2017; 29: 292–301.
Aksoy M and Lehmann H. The First Observation of Sickle-Cell Hand;aelig;moglobin E Disease. Nature 179: 1248–1249.
Altay C, Niazi GA, Huisman THJ. Hb E and Hb E-Like Variants in Individuals from Turkey. Hemoglobin 1987; 5: 743–748.
Balgir RS. Genetic Epidemiology of the Three Predominant Abnormal Hemoglobins in India. J Assoc Physicians India 1996; 44: 25–28.
Balgir RS. The Spectrum of Haemoglobin Variants in Two Scheduled Tribes of Sundargarh District in North-Western Orissa, India. Ann Hum Biol 2005; 32: 560–573.
Charneski L and Congdon HB. Effects of Antiplatelet and Anticoagulant Medications on the Vasoocclusive and Thrombotic Complications of Sickle Cell Disease: A Review of the Literature. Am J Health-Syst Pharm 2010; 67: 895–900.
Chhotray GP, Dash BP, Ranjit MR, Cohla RB, Mohanty D. Haemoglobin E/Beta-Thalassaemia - an Experience in the Eastern Indian State of Orissa. Acta Haematol 2003; 109: 214–216.
Chhotray GP, Dash BP, Ranjit MR. Spectrum of Hemoglobinopathies in Orissa, India. Hemoglobin 2004; 28: 117–122.
Colah RB, Mukherjee MB, Ghosh K. Sickle Cell Disease in India. Curr Opin Hematol 2014; 21: 215–223.
Dash BP and Kar BC. Sickle Cell-Haemoglobin Dpunjab Disease in Orissa State, India. HAEMA 2006; 9: 652–654.
Eaton WA and Bunn HF. Treating Sickle Cell Disease by Targeting HbS Polymerization. Blood 2017; 129: 2719–2726.
Eichhorn RF, Buurke, EJ, Blok P, Berends MJH, Jansen CL. Sickle Cell-like Crisis and Bone Marrow Necrosis Associated with Parvovirus B19 Infection and Heterozygosity for Haemoglobins S and E. J Intern Med 1999; 245: 103–106.
Flatz G. Hemoglobin E: Distribution and Population Dynamics. Humangenetik 1967; 3: 189–234.
Frenette PS and Atweh GF. Science in Medicine Sickle Cell Disease: Old Discoveries, New Concepts, and Future Promise. J Clin Investig 2007; 117: 850–854.
Fucharoen S and Weatherall DJ. The Hemoglobin E Thalassemias. Cold Spring Harb Perspect 2012; 2: a011734.
Howard J. Sickle Cell Disease: When and How to Transfuse. Hematology (United States) 2016; 2016: 625–631.
Iyer S, Sakhare S, Sengupta C, Velumani A. Hemoglobinopathy in India. Clinica Chimica Acta 2015; 444: 229–233.
Jit BP, Mohanty PK, Pradhan A, Purohit P, Das K, Patel S, Meher S, Sinha S, Mohanty JR, Behera RK, Das P. Erythrocyte cAMP in Determining Frequency of Acute Pain Episodes in Sickle Cell Disease Patients from Odisha State, India. Hemoglobin 2019; 43: 88-94.
Kate SL and Lingojwar DP. Epidemiology of Sickle Cell Disorder in the State of Maharashtra. Int J Hum Genet 2002; 2: 161-167.
Khamees I, Rozi W, Yassin MA. Acute chest syndrome in sickle cell disease/HBE patient, A case report. Clin Case Rep 2021; 9: e04575.
Kishore B, Khare P, Gupta RJ, Bisht S, Majumdar K. Hemoglobin E Disease in North Indian Population: A Report of 11 Cases.” Hematology 2007; 12: 343–347.
Masiello D, Heeney MM, Adewoye AH, Eung SH, Luo HY, Steinberg MH, Chui DHK. Hemoglobin SE Disease - A Concise Review.” Am J Hematol 2007; 82: 643–649.
Mishra P, Pati HP, Chatterjee T, Dixit A, Choudhary DR, Srinivas MU, Mahapatra M, Choudhry VP. Hb SE Disease: A Clinico-Hematological Profile. Ann Hematol 2005; 84: 667–670.
Newton CR, Graham A, Heptinstall LE, Powell SJ, Summers C, Kalsheker N, Smith JC, Markham AF. Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS). Nucleic Acids Res 1989; 17: 2503–2516.
Pajak A, Li JC, Liu A, Nazare S, Smith B. Hemoglobin SE Disease Presenting as a High-Altitude Massive Splenic Infarction Complicated by Hemorrhagic Conversion and Splenectomy. Cureus 2020; 12: 9–14.
Purohit P, Mohanty P, Panigrahi J, Patel S. Infection with Plasmodium falciparum malaria in a patient with homozygous hemoglobin E. Muller J Med Sci Res 2019; 10: 36.
Rey KS, Unger CA, Rao SP, Miller ST. Sickle cell-hemoglobin E disease: clinical findings and implications. J Pediatr 1991; 119: 949–951.
Sahu P, Purohit P, Mantri S, Tudu R, Nayak J, Agrawalla SK, Behera SK, Patro MK, Karmee N, Tripathy D, Mishra B, Mishra DP. Spectrum of hemoglobin disorders in southern Odisha, India: a hospital based study. Porto Biomed J 2021; 6: e126.
Sahu PK, Pati SS, Mishra SK. Genotype-phenotype correlation of and;beta;-thalassemia spectrum of mutations in an Indian population. Hematol Rep 2012; 4: e9.
Tay SH, Teng GG, Poon M, Lee VKM, Lim, AYN. A case of hemoglobin SE presenting with sickle cell crisis: Case report and histological correlation. Ann Acad Med Singap 2011; 40: 552–553.
Thornburg CD. Hemoglobin SE Disease in Maine and Severe Thalassemia in New Hampshire. Pediatr Hematol Oncol J 2009; 31: 307.
Vishwanathan C, Agarwal MB, Bichile LS, Bhave AB. Double heterozygosity for hemoglobin S and E. Indian Pediatr 1992; 29: 895–897.
Wajcman H and Moradkhani K. Abnormal haemoglobins: Detection and; characterization. Indian J Med Res 2011; 134: 538–546.
Weatherall DJ and Clegg JB. Public Health Reviews Inherited haemoglobin disorders: an increasing global health problem. Bull. World Health Organ 2001; 79: 704–712.
Williams TN and Weatherall, DJ. Health Burden of the Hemoglobinopathies. Cold Spring Harb Perspect Med 2012; 2: 1–14.</References>
</References>
</Journal>
</Article>
</ArticleSet>